Merz Annual Report:
»Opening up perspectives. Developing markets.«

For over 100 years, Merz has taken responsibility for human health with innovative medicines and products. The pharmaceutical company's goal is to noticeably improve the quality of life of patients and consumers and to prevent and cure diseases. Merz attaches great importance to new therapeutic approaches: in neurology in view of an increasingly older population, in aesthetic medicine in view of the growing importance of a natural and beautiful appearance for well-being. In order to remain one of the leading companies in its markets in the future, Merz has been consistently geared towards international competitiveness in recent years. The company is going its own way and is implementing a focused and differentiated internationalization. Management is always focused on the claim to leadership in the targeted markets: Only where it succeeds in being among the top through its own efforts and the location is of particular strategic importance will its own country structures be set up and expanded. If this is not possible, the company looks for strong partners. Merz is represented in more than 70 countries worldwide through sales cooperations and licensing partners.